A Study of Ustekinumab in Pediatric Participants (U-POPS) With Juvenile Psoriatic Arthritis or Psoriasis

NCT05252533 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Juvenile Psoriatic Arthritis
Psoriasis
Arthritis, Juvenile

Interventions

DRUG: Ustekinumab

Sponsor

Janssen Research & Development, LLC